BioDot, Inc
Erica Phillips has over 20 years of experience in various roles within the healthcare and genetics field. Erica is currently the Sales Director for Molecular Diagnostics in North America at BioDot, Inc. Prior to this, they held positions at Oxford Gene Technology as a Southeast Account Manager and later as an Inside Sales Manager for North America. Erica also served as a Clinical Cytogenetics Supervisor at Duke University Health System and as a Laboratory Manager at Prenatal Screening, where they played a crucial role in the development and validation of prenatal screening programs. Erica has extensive experience in managing cytogenetics laboratories and ensuring compliance with quality control and assurance programs. Erica has a strong background in genetics and has held roles as a Cytogenetic Technologist at GeneCare Medical Genetics, LabCorp, and Cytogenetic Karyotyper.
Erica Phillips attended the University of North Carolina Wilmington from 1999 to 2003, where they earned a Bachelor of Science degree in Biology.
This person is not in any offices
BioDot, Inc
For over 25 years, BioDot has developed proprietary, quantitative technologies for the dispensing of low volumes of fluids (picoliter to microliter) that meet the needs of industrial, life science, diagnostic, and medical products. BioDot is division of ATS Automation - Life Sciences Division On March 24, 1994, BioDot established itself as a company in Southern California with its patented BioJet™, "Drop on Demand", non-contact, dispensing technology. At that time, BioDot focused on using this technology to dispense discrete drops, or a series of drops to form a line. This quantitative, enabling technology was used predominantly in Lateral Flow Test or Flow Through Test applications in the diagnostic marketplace. Over the following years, BioDot expanded its expertise outside of dispensing, and developed lamination and cutting technologies. In parallel, it expanded its application abilities to enable scientists to utilize the quantitative dispensing and develop more sophisticated point of care tests, such as: - Glucose or other Microfluidic Sensors - Immunoblots or Allergy Tests - Cell, DNA, or Protein Arrays - Compound Handling In addition, BioDot developed modular workstations and enabled customers to work in either a "Batch" or "In-Line" Approach, depending on their materials and processes, as well as short and long goals. Now, in our 25th year, BioDot continues to be a leading supplier of system tools for the research, development and commercialization of diagnostic tests. With our continuously expanding product portfolio, BioDot has marketed systems for the development and manufacture of Microfluidics. We also have systems for the Life Sciences and the Molecular & Point of Care Diagnostics. By expanding our global presence with entities in China and the UK/Europe, BioDot has a commitment to fully understand our customer's requirements, globally. #lateralflow, #biosensor, #labonachip, #biochip, #dispensing